橄榄-脑桥-小脑萎缩与“十字征”八例

目的探讨MRI脑桥十字征的橄榄-脑桥-小脑萎缩(OPCA)患者临床与影像学特点。方法总结8例经临床诊断为OPCA,分析其临床特点及影像学特征表现。结果 8例患者的临床表现均以小脑性共济失调和脑干功能受损伴有自主神经功能障碍为主,MRI在脑桥轴位T2WI上均出现典型的"十字征"。结论以小脑性共济失调和脑干功能受损为主要表现的OPCA患者,多伴有自主神经功能障碍,脑桥十字征是MRI特征性表现之一,有助于该病的诊断。     

橄榄脑桥小脑萎缩20例临床分析

目的探讨橄榄脑桥小脑萎缩的临床表现和影像学检查特点,以便早期诊断并改善患者预后。方法回顾性分析经临床诊断的20例橄榄脑桥小脑萎缩患者的相关资料。结果橄榄脑桥小脑萎缩患者临床以小脑性共济失调、言语不清、排尿功能障碍、帕金森症状等最常见。16例患者头颅磁共振检查结果示脑萎缩,主要为小脑和脑干萎缩。结论橄榄脑桥小脑萎缩临床以小脑性共济失调为主要表现,言语障碍较继往报道发生率高,头颅磁共振可表现为小脑、脑干萎缩,并可一定程度上反映病程。     

多系统萎缩患者的临床表现、MRI、肛门括约肌肌电图分析

目的分析多系统萎缩患者(MSA)临床表现、头部MRI、肛门括约肌肌电图改变特点,探讨它们在MSA诊断的价值。方法按Gilman诊断标准,回顾性分析46例MSA患者的临床资料、头部MRI及肛门括约肌肌电图检查结果。结果符合很可能MSA39例,可能MSA7例,其中MSA-A型24例,主要临床表现为自主神经功能障碍;MSA-C型16例,主要表现为小脑性共济失调;MSA-P型6例,主要表现为锥体外系症状。MRI显示部分MSA-A患者出现大脑皮质萎缩,小脑改变较轻;MSA-C型主要表现为延髓、脑桥、小脑萎缩;MSA-P主要病变在壳核和苍白球,而小脑、脑桥、延髓病变早期可以不明显。部分患者出现脑桥十字征和壳核裂隙征。36例患者做肛门括约肌肌电图检查,全部出现神经源性损害。结论 MSA早期诊断难度大,结合临床表现、头部MRI检查及肛门括约肌肌电图检查,可提高MSA的诊断准确率。     

橄榄脑桥小脑萎缩与“十字征”

目的:探讨橄榄脑桥小脑萎缩(OPCA)的临床和影像学特点。方法:对1例橄榄脑桥小脑萎缩患者的临床资料进行回顾性分析并文献复习。结果:本病以小脑共济失调为首发表现,部分出现植物神经系统受损、锥体束或锥体外系症状。影像学除脑干变细、小脑体积变小外,可出现特征性的十字征表现。结论:因该病和某些小脑变性疾病表现相重叠,且无有意义的生化标记物,故其影像学十字征的发现对此病的诊断和鉴别诊断意义重大。     

多系统萎缩的临床与MRI特征

目的探讨多系统萎缩(MSA)的临床与MRI特征及其对临床亚型诊断的意义。方法回顾性分析28例MSA患者的临床及MRI资料。结果橄榄脑桥小脑萎缩(OPCA)以小脑体征(75.0%)突出,MRI表现为脑桥萎缩(91.7%)、小脑蚓部萎缩(91.7%),第四脑室扩大(83.8%),T2WI出现脑桥、小脑对称性高信号(63.6%)及脑桥十字征;纹状体黑质变性(SND)以锥体外系症状(80.0%)明显,MRI改变多位于基底节核团,表现为壳核萎缩(60.0%),T2WI示壳核外侧缘缝隙样高信号(80.0%);ShyDrager综合征(SDS)以自主神经症状(81.8%)为主,出现早且重,MRI未见特异性变化。结论MRI有助于提高MSA及其亚型诊断。脑桥萎缩、T2WI高信号改变,尤其是脑桥十字征的出现有助于OPCA诊断;壳核萎缩与T2WI壳核外侧缘缝隙样高信号改变支持SND诊断。     

16例多系统萎缩的临床与MRI分析

目的探讨多系统萎缩（MSA）的临床及MRI特征。方法对临床诊断的16例MSA患者的临床及MRI资料进行回顾性分析。结果根据临床资料及MRI结果分为3种类型：（1）11例橄榄体桥脑小脑萎缩（OPCA）,其中小脑共济失调为主10例,脑MRI明显可见延髓萎缩、桥脑萎缩及小脑萎缩,其中桥脑十字征9例,小脑中脚萎缩5例;（2）3例Shy-Drager综合征（SDS）,10例中以植物神经功能紊乱为主要表现2例,壳核边缘高信号和壳核萎缩;（3）2例纹状体-黑质变性（SND）,首发症状均因锥体外系表现而早期误诊为帕金森病（PD）,脑MRI示壳核萎缩,其中1例T2WI壳核及纹状体低信号。结论 MSA是一组神经系统多部位变性综合征,MRI对MSA的诊断有较肯定的意义。     

Shy-Drager综合征12例临床分析

目的探讨Shy-Drager综合征的临床表现和影像学特点,以便早期诊断并改善患者预后。方法回顾性分析经临床诊断的12例Shy-Drager综合征患者的相关资料。结果Shy-Drager综合征患者临床以小便障碍、直立性低血压、性功能障碍、共济失调最常见。8例患者头颅磁共振检查结果示脑萎缩,主要为小脑和脑干萎缩。结论Shy-Drager综合征临床以自主神经功能障碍为主要表现,合并小脑症状发生率高,头颅磁共振可表现为小脑、脑干萎缩。     

Shy—Drager综合征12例临床分析

目的探讨Shy—Drager综合征的临床表现和影像学特点，以便早期诊断并改善患者预后。方法回顾性分析经临床诊断的12例Shy-Drager综合征患者的相关资料。结果Shy-Drager综合征患者临床以小便障碍、直立性低血压、性功能障碍、共济失调最常见。8例患者头颅磁共振检查结果示脑萎缩，主要为小脑和脑干萎缩。结论Shy—Drager综合征临床以自主神经功能障碍为主要表现，合并小脑症状发生率高，头颅磁共振可表现为小脑、脑干萎缩。     

多系统萎缩的认知障碍研究进展

<正>多系统萎缩(multiple system atrophy,MSA)于1969年被首次命名,是一种中老年起病,表现为进展性自主神经功能障碍,伴小脑性共济失调症状、帕金森症状、及锥体束征为主要临床特征的神经系统退行性疾病~([1])。病理学涉及橄榄脑桥小脑(olivopontocerebellar,OPCA)和纹状体黑     

磁共振成像表现为双侧桥臂病变的多系统萎缩4例报告及临床分析

<正>多系统萎缩(multiple system atrophy,MSA)是一种病因不明的以进展性自主神经功能障碍,伴帕金森症状、小脑性共济失调和锥体束征为主要临床表现的神经系统变性疾病~[1]。MSA仍以病理诊断为"金标准",神经影像学以壳核、小脑、脑桥萎缩、脑桥基底部"十字征"、壳核背外侧缘"裂隙     

多系统萎缩患者143例临床和影像学特征分析

目的 探讨多系统萎缩(MSA)不同亚型的临床和影像学特征及其相关性.方法 对143例符合1999年Gilman诊断标准的MSA患者进行临床分型和诊断分级,根据Horimoto分期对108例影像学出现异常的患者脑桥十字征和壳核裂隙征进行分析,并探讨不同临床亚型及病程与影像学异常的相关性.结果 143例MSA患者男女比例为1.3:1,其中MSA小脑萎缩型(MSA-C)93例,MSA帕金森型(MSA-P)39例,两者同时出现的即为MSA-P+C型11例;很可能的MSA 90例,可能的MSA 53例.108例MSA患者影像学出现异常,其中MSA-C型患者36例(36/76,47%)出现脑桥十字征,10例(10/76,13%)出现壳核裂隙征;MSA-P型患者6例(6/24,25%)出现脑桥十字征,6例(6/24,25%)出现壳核裂隙征.MSA-C型中病程较短的患者脑桥十字征分期较早.结论 本组病例中MSA-C型患者明显多于MSA-P型,可能与种族遗传背景有关.脑桥十字征和壳核裂隙征为MSA患者的显著影像学特征,MSA临床分型与影像学特征具有一定的相关性,其中脑桥十字征在MSA-C型较为显著,壳核裂隙征在MSA-P型较为显著.     

Pyramidal tract degeneration in multiple system atrophy: the relevance of magnetization transfer imaging.

The clinical features of multiple system atrophy (MSA) include four domains: autonomic failure/urinary dysfunction, Parkinsonism, cerebellar ataxia, and corticospinal tract dysfunction. Although the diagnosis of definite MSA requires pathological confirmation, magnetic resonance imaging (MRI) studies have been shown to contribute to the diagnosis of MSA. Although pyramidal tract dysfunction is frequent in MSA patients, signs of pyramidal tract involvement are controversially demonstrated by MRI. We evaluated the pyramidal involvement in 10 patients (7 women) with clinically probable MSA, detecting the presence of spasticity, hyperreflexia, and Babinski sign, as well as demonstrating degeneration of the pyramidal tract and primary motor cortex by MRI in all of them. Our article also discusses key radiological features of this syndrome. In MSA, pyramidal tract involvement seems to be more frequent than previously thought, and the clinicoradiological correlation between pyramidal tract dysfunction and degeneration may contribute to the understanding of the clinical hallmarks of MSA. MRI may also add information regarding the differential diagnosis of this syndrome.     

Multiple system atrophy presenting as parkinsonism: clinical features and diagnostic criteria.

To evaluate the possibility that parkinsonian signs may be the only presenting feature of multiple system atrophy (MSA), parkinsonian patients were studied who had no atypical clinical signs and had no symptoms of autonomic dysfunction, but who reported that they had not experienced the anticipated good response to dopaminergic treatment. These stringent criteria identified 20 patients from a series of 298 consecutive parkinsonian outpatients. The following clinical pointers were analysed: (a) rate of disease progression; (b) symmetry of parkinsonian symptoms and signs; (c) occurrence of resting tremor during the first three years from onset. In addition, all patients underwent (d) acute and chronic challenge with dopaminergic drugs; (e) cardiovascular reflex autonomic function tests; (f) high field MRI. Rapid progression of disease was seen in 45% of patients, onset was symmetric in 25%, tremor was absent at onset in 70%, response to dopaminergic drug challenges was inadequate in 40%, abnormal cardiovascular reflexes occurred in 50%, and some abnormal MRI finding occurred in 35% of cases. Each of these features was equally weighted by giving to each patient a 0 to 6 point score corresponding to the number of abnormal findings. Fifteen patients scoring higher than 1 were considered at risk for having MSA: five of them were classified as clinically possible (score 2), six as clinically probable (score 3-4), and four patients were classified as clinically definite multiple system atrophy (score 5). The six pointers considered were variably combined in each patient, none of them being universally abnormal in patients with high scores. The patients were followed up for a mean 2.1 (SEM 0.65) years. All but one of the 10 patients prospectively classified as probable or definite MSA developed unequivocal clinical signs of fully symptomatic MSA. A receiver operator characteristic cure was plotted for the prospective score based on follow up diagnosis. The best compromise for trade off between sensitivity and specificity was a cut off value at a score of 3. The sensitivity and specificity of the individual pointers considered to predict fully symptomatic MSA varied considerably, and no single item could predict whether patients presenting with just parkinsonian signs went on during the two year follow up period to develop fully symptomatic MSA. Instead, the number of abnormalities offered a predictive value for the clinical prognosis of these parkinsonian patients.     

多系统萎缩44例的临床与神经电生理特点分析

目的 探讨临床和神经电生理检查对于多系统萎缩(MSA)的诊断价值。方法 对44例MSA患者分组分析其临床特点、肌电图(EMG)、神经传导速度(NCV)、躯体感觉诱发电位(SEP)、运动诱发电位(MEP)、脑干听觉诱发电位(BAEP)及视觉诱发电位(VEP)。并比较临床表现和电生理检查结果在各组间的差异。结果 本组患者以自主神经功能障碍和小脑生共济失调的异常率最高(88．6％)。帕金森综合征出现率在各组间差异有显著意义(P值分别为0．027、0．007、0．025)，卧立位血压异常在拟诊组和可能组间差异有显著意义(76．5％、18．2％)。EMG和NCV的异常率为38．1％，各组间出现率有不同。各种诱发电位的异常出现率在分组比较中无显著性差异。结论 仅凭临床表现无法对：MSA进行分组。各项神经电生理检查中以BAEP的阳性率最高。EMG和NCV结果在各组之间的差异提示该项检查对于MSA的分组可能有一定的帮助。     

Sympathetic neural outflow directly recorded in patients with primary autonomic failure: clinical observations, microneurography, and histopathology

We evaluated 2 patients with primary autonomic failure, without clinical peripheral neuropathy. One had primary autonomic failure alone (PAF), and the other had autonomic failure and multiple system atrophy (MSA). Direct intraneural recordings demonstrated a marked reduction of sympathetic efferent nerve impulse activity in the PAF patient. The patient with MSA had spontaneous bursts of sympathetic nerve impulses that confirmed the functional integrity of post-ganglionic sympathetic efferent neurons. Neurosecretory activity of these neurons correlated with the electrophysiologic findings. The PAF patient had markedly reduced supine norepinephrine (NE) levels that did not rise upon standing. The supine NE level in the MSA patient was normal. Morphometric study of biopsied sural nerve in the MSA patient showed that unmyelinated fibers were normal, whereas the nerve of the PAF patient showed clear evidence of past degeneration. We suggest that the primary preganglionic sympathetic defect in MSA releases viable postganglionic sympathetic efferents from central control. Decentralized postganglionic elements may fire spontaneously, thus activating peripheral effectors and providing potentially useful signs and symptoms for differential diagnosis.     

进行性核上性麻痹与多系统萎缩的头部MRI和FDG-PET比较

目的对比研究进行性核上性麻痹(PSP)与多系统萎缩(MSA)的脑干MRI表现和头部葡萄糖代谢特征。方法对11例PSP患者、37例MSA患者和43例健康对照进行头部MRI平扫检查,并计算MRI正中矢状面T1加权像上中脑截面面积,其中5例PSP和19例MSA进行了18F-FDG PET检查。结果(1)MRI:11例PSP正中矢状位T1加权像均可见中脑上缘平坦或凹陷表现,呈"蜂鸟征",而MSA患者和健康对照组未见上述表现。37例MSA患者中有34例轴位T2加权像桥脑可见"十字征"样长T2异常信号。PSP患者正中矢状位T1加权像上中脑截面面积分别低于MSA组和健康对照组(P<0.01)。(2)PET:PSP组主要表现为对称性额叶低代谢;MSA组主要表现为额、顶、颞叶普遍低代谢,纹状体对称性代谢降低,丘脑代谢高于纹状体。结论PSP中脑MRI特征和头部葡萄糖代谢特征与MSA和健康对照有明确差异,有助于PSP与MSA的鉴别诊断。     

Longitudinal MRI study of multiple system atrophy – when do the findings appear,and what is the course?

Several investigators have revealed features of multiple system atrophy (MSA) by magnetic resonance imaging (MRI). For use in clinical diagnosis, we determined the exact time when two main features of pontine and putaminal intensity changes appeared. Furthermore, in order to reveal the course from when the disorder first appeared and how it spread, we also investigated the course of MRI findings and differences between clinical subtypes. The cranial MRI of 42 patients with MSA were longitudinally studied including comments on the so called “cross sign” of pontine T2 high intensity, which was divided into 6 stages, and also on the linear T2 high intensity of the dorsolateral side of the putamen (“putaminal slit”) which was divided into 4 stages. Patients were classified as 16 MSA-C, 7 autonomic dominant type (MSA-A), and 19 MSA-P. The age at onset ranged from 41 to 74 years (mean, 55 ± 9). The duration of the disease in the MRI study ranged from 1 to 24 years. The pontine “cross sign” was completed (shows Cross, stage IV) earlier in MSA-C mainly before 5 years, later in MSA-P and even much later in MSA-A. Regarding the “putaminal slit”, MSA-P shows earlier bilateral changes (stage II), mostly before 3 years, compared with MSA-C, which requires 4 years to reveal even a unilateral change (stage I), or MSA-A which requires even more time. MRI findings showed a tendency to relate to clinical findings, since MSA-C exhibits “cross sign” completion earlier than bilateral “putaminal slit”; however, MSA-P shows bilateral “putaminal slit” earlier than “cross sign”, and MSA-A requires much more time to show both. Clinically, MSA-C, MSA-A, or MSA-P showed different MRI courses so that three subtypes could be defined also with MRI findings. Therefore these observations are useful not only for diagnosis of MSA itself, but also to distinguish clinical subtypes (MSA-C, MSA-A, or MSA-P) which have different rates of lesion progression. Received: 5 September 2001, Received in revised form: 10 December 2001, Accepted: 17 December 2001     

Conventional magnetic resonance imaging in confirmed progressive supranuclear palsy and multiple system atrophy

Conventional magnetic resonance imaging (cMRI) is often used to aid the diagnosis of progressive supranuclear palsy (PSP) and multiple system atrophy (MSA), but its ability to predict the histopathological diagnosis has not been systematically studied. cMRI from 48 neuropathologically confirmed cases, including PSP (n = 22), MSA (n = 13), Parkinson's disease (PD) (n = 7), and corticobasal degeneration (n = 6), and controls (n = 9) were assessed blinded to clinical details and systematically rated for reported abnormalities. Clinical diagnosis and macroscopic postmortem findings were retrospectively assessed. Radiological assessment of MRI was correct in 16 of 22 (72.7%) PSP cases and 10 of 13 (76.9%) MSA cases with substantial interrater agreement (Cohen's kappa 0.708; P < .001); no PSP case was misclassified as MSA or vice versa. MRI was less sensitive but more specific than clinical diagnosis in PSP and both more sensitive and specific than clinical diagnosis in MSA. The “hummingbird” and “morning glory” signs were highly specific for PSP, and “the middle cerebellar peduncle sign” and “hot cross bun” for MSA, but sensitivity was lower (up to 68.4%) and characteristic findings may not be present even at autopsy. cMRI, clinical diagnosis, and macroscopic examination at postmortem have similar sensitivity and specificity in predicting a neuropathological diagnosis. We have validated specific radiological signs in pathologically confirmed PSP and MSA. However, the low sensitivity of these and macroscopic findings at autopsy suggest a need for imaging techniques sensitive to microstructural abnormalities without regional atrophy. © 2012 Movement Disorder Society     

Auditory brainstem responses in patients with autonomic failure with Parkinson's disease and multiple system atrophy

Auditory brainstem responses (ABRs) were examined in six patients with autonomic failure with Parkinson's disease (AF with PD) and 10 patients with autonomic failure with multiple system atrophy (AF with MSA), all of which showed marked parkinsonian features as a principal sign. We designated the central abnormalities of ABRs as prolongation of latencies (wave III or V) and interpeak latencies (IPLs; I-III, I-V, and III-V IPL) or decreased amplitude ratios of wave III or V to those of wave I (less than 1.0). None of the patients with AF with PD showed abnormalities in ABRs. In contrast, in those with AF with MSA, the peak latencies or IPLs were prolonged in two of the 10 patients, and the amplitude ratios of wave III or V to those of wave I were decreased in other two of these patients. Moreover, both prolongation of latencies and a decreased ratio were observed in other one. Overall, five of the 10 patients with AF with MSA showed central abnormalities in ABRs. It is clinically difficult to differentiate AF with PD from AF with MSA, particularly when no cerebellar signs are apparent in AF with MSA patients. When central abnormalities of ABRs are observed in AF patients, AF with MSA should be suspected rather than AF with PD. In conclusion, ABRs provide useful information for the differential diagnosis of AF with PD and AF with MSA.